Biotech Stocks Cruise to New Highs While Boosting Healthcare Sector…Update-3 DEC 5…alert
Update-3 12/5/25…3:15 PST…EYPT still strong up another 5%;.ADPT down another big 14%-Benziga has a note on a Natera buyout that must be related to drop in ADPT stock. More later but more competition is coming to blood cancers so watch ASH-American Society for Hematology coming up...
Biotech Deals Propel Sector to New 2025 Highs…Update-4…A bullish signal for upcoming week 11/23.
11/24/25…Update-4—11:00a EST—–GREEN SCREEN DAY in early trading with both IBB and XBI at new 2025 highs, laggard ARKG catching up at $29.34 up over 3%. Many 4% movers from our trading list—DNTH new buy, ADPT, ABOS, DNLI, GH, PACB, RYTM,TXG,TEM, and XNCR at a new...
Large Cap Biopharmaceuticals Lead the Way for Healthcare Investors…Update-1
Update-1 11/15 Merck buys Cedara for $9.2B for long acting Flu drug. An alternative to vaccines? CDTX up 105% IBB at $164.30 approaching highs of AUG 2021 of $177. Large Cap Biopharma Stocks Lead the Way for Healthcare Investors Biopharma stocks offer growth plus value with dividends.Standouts...
What’s Behind the Moves in the Healthcare Sector: Many Options for investing-Biotech, Medtech, Tools.
An abrupt reversal from “Risk-Off” sentiment launched a rally in some SMID biotechs, precious metals and AI / Semiconductor stocks. The NAZ was up 2.25%. Health Science stocks did well today: Precision oncology, biopharmaceuticals weight-loss /obesity A volatile choppy week for the...
Healthcare Stocks are Coming Back Fast Boosted by Biotechs…Update-6 COGT !…. And a choppy “risk off market”, a deal on weight -loss drugs.
Update-6 11/10/25…SMID Biotechs in a romp!…Cogent Biosciences (COGT) up 130% on Phase 3 Study. XBI up 1.5% at $110 level. Update-5…11:11a 11/7/25…XBI slices thru support of 20 day down 2.4% to $106 level-a red screen day. Moreover all SMID biotech indices are down: IWM...